DroneShield’s $730 Million Bet Hangs on Regulatory Resolution as Shares Sink 23% in a Week

Counter-drone firm DroneShield faces punishing disconnect: soaring revenue and $2.2B pipeline overshadowed by ASIC investigation and 43% share dilution, stock at oversold levels.

The counter?drone specialist DroneShield is caught in a punishing disconnect: operational metrics that would normally excite investors are being steamrollered by a regulatory probe and relentless share dilution. The stock closed Friday at €1.28, shedding over 9% on the day and capping a weekly rout of nearly 23%. In the past 30 days a third of the company’s market value has evaporated, leaving the relative strength index at a deeply oversold reading of about 20.

At the heart of the sell?off lies an investigation by the Australian Securities and Investments Commission. ASIC is examining stock sales by former CEO Oleg Vornik and two other directors that took place in November 2025. Shortly after those transactions the company announced a multi?million?dollar order, only to withdraw the statement hours later. The scrutiny, which began in May 2026, has poisoned investor trust. Until the regulator’s work is done, every positive operating development is met with scepticism.

A board addition and a push into Europe

Amid the turmoil, the company is making structural moves. Retired Rear Admiral Lee Goddard joins the supervisory board on Tuesday, bringing three decades of defence?sector experience and ties to military procurement in Australia and the United States. His brief is to better align DroneShield’s technology with government requirements.

At the same time, the company is deepening its European footprint. A supply?chain campaign has just kicked off in Poland, the largest relative NATO spender and a keen investor in autonomous systems. An Amsterdam headquarters is already operational, and the first locally produced systems are expected to roll off the line there in the middle of the year.

Soaring revenue, but dilution dilutes the impact

The financial headlines look strong. Revenue for the first quarter doubled to roughly A$74?million, and operating cashflow stayed positive. The balance sheet carries no debt and a healthy cash pile. For the full 2025 financial year, revenue surged 276% to A$216.5?million, and the company has already booked A$155?million in locked?in revenue for 2026.

Yet the denominator is expanding rapidly. The number of shares outstanding swelled 43% over the past year, and in mid?June a further 823,111 new shares were quoted on the ASX. The resulting dilution weighs heavily on per?share metrics and spooks existing holders. Underlining the leadership transition, long?time chief technology officer Angus Bean has taken the CEO helm.

A pipeline worth $2.2?billion and a single make?or?break contract

DroneShield’s global sales pipeline now encompasses 312 projects with a combined value of A$2.2?billion, half of which come from Europe and the UK. Towering above everything is a single potential order worth A$730?million. Management expects the award to be decided in the second half of 2026, and a win would be an immediate catalyst.

In the nearer term, a US$24.9?million contract for mobile and stationary counter?drone systems with a US government agency, signed in early June, provides a tangible proof point.

Software transition still in its infancy

Management is pushing to shift the business model toward recurring software revenue. Software sales tripled in the first quarter, but they still represent only about 7% of total revenue. The board has set a target of 30% by 2030 — an ambitious stretch from today’s base.

The half?year results, due in August, will offer the first concrete data on the profitability of the new European production lines. Until then, the ASIC investigation dictates the narrative.

Analyst views split wide open

The market cannot agree on how to value this business. Ord Minnett initiated coverage with a “Lighten” rating and a price target of A$2.28. At the other end, some analysts see fair value as high as A$5.00. The consensus range of A$2.30 to A$3.72 reflects profound uncertainty about whether rapid growth will be consumed by dilution and governance risk.

Technically, the stock is now trading about 34% below its 50?day moving average, underscoring the severity of the sell?off. The next decisive move — whether from a regulatory clearance, a contract award, or another dilutive event — will determine which side of the valuation debate proves right.